180 Wealth Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

180 Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$0.28 - $1.16 $1,072 - $4,441	-3,829 Reduced 14.93%	21,810 $7,000
Q1 2024 Apr 15, 2024	BUY	$1.06 - $1.67 $165 - $260	156 Added 0.61%	25,639 $29,000
Q4 2023 Jan 24, 2024	SELL	$1.26 - $1.79 $2,118 - $3,008	-1,681 Reduced 6.19%	25,483 $43,000
Q3 2023 Oct 31, 2023	BUY	$1.61 - $2.54 $344 - $543	214 Added 0.79%	27,164 $49,000
Q2 2023 Jul 11, 2023	SELL	$1.14 - $1.95 $3,100 - $5,304	-2,720 Reduced 9.17%	26,950 $50,000
Q1 2023 Apr 07, 2023	SELL	$1.2 - $2.19 $14 - $26	-12 Reduced 0.04%	29,670 $39,000
Q4 2022 Feb 02, 2023	BUY	$1.63 - $3.52 $1,799 - $3,886	1,104 Added 3.86%	29,682 $50,000
Q3 2022 Oct 12, 2022	SELL	$0.73 - $3.74 $1,106 - $5,669	-1,516 Reduced 5.04%	28,578 $89,000
Q2 2022 Jul 11, 2022	BUY	$2.2 - $4.2 $8,212 - $15,678	3,733 Added 14.16%	30,094 $72,000
Q1 2022 Apr 22, 2022	BUY	$2.83 - $8.69 $38,810 - $119,174	13,714 Added 108.44%	26,361 $101,000
Q4 2021 Jan 26, 2022	BUY	$8.31 - $14.92 $105,096 - $188,693	12,647 New	12,647 $67,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on 180 Wealth Advisors, LLC with notifications on news.